Therapy for antiphospholipid miscarriages: Throwing the baby out with the bathwater?
Cecilia Beatrice ChighizolaYehuda ShoenfeldPier Luigi MeroniPublished in: American journal of reproductive immunology (New York, N.Y. : 1989) (2017)
The association of LMWH and LDASA is the most effective therapeutic option for pregnant aPL-positive women. The lack of a clear demonstration of the pharmacological action of LMWH/LDASA should urge to further invtrestigate the pathophysiology of aPL-associated miscarriages.